NDAORAL, RECTALSOLUTION
Approved
Jan 1958
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
GASTROGRAFIN (diatrizoate meglumine and diatrizoate sodium) by Bracco is clinical pharmacology the most important characteristic of contrast media is the iodine content. First approved in 1958.
Drug data last refreshed 20h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Gastrografin is an oral/rectal contrast medium containing diatrizoate meglumine and diatrizoate sodium, used for radiographic visualization of the gastrointestinal tract. The iodine content provides radiodensity for diagnostic imaging of the esophagus, stomach, small intestine, and colon. It works through osmotic effects and minimal GI absorption, allowing opacification without systemic pharmacological activity.
LOE Approaching
Product is in late-stage lifecycle with approaching loss of exclusivity, signaling potential downsizing or transition of commercial teams.
Mechanism of Action
CLINICAL PHARMACOLOGY The most important characteristic of contrast media is the iodine content. The relatively high atomic weight of iodine contributes sufficient radiodensity for radiographic contrast with surrounding tissues. Diagnostic enteral radiopaque agents have few known pharmacological…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Worked on GASTROGRAFIN at Bracco? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.